Circulating Progenitor Cell Therapeutic Potential Impaired by Endothelial Dysfunction and Rescued by a Collagen Matrix
Angiogenic cell therapy is currently being developed as a treatment for coronary artery disease (CAD); however, endothelial dysfunction (ED), commonly found in patients with CAD, impairs the ability for revascularization to occur. We hypothesized that culture on a collagen matrix will improve surviv...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2012
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/23099 http://dx.doi.org/10.20381/ruor-5275 |